With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.246047-72-3,(1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium,as a common compound, the synthetic route is as follows.
The catalyst precursor 620g and alkenyl ligands340g was added to a 10L reactor was added dichloromethane solvent 5L, cuprous chloride was added 150g, it was heated under nitrogen at 30 until starting material disappeared the reaction was cooled to room temperature, filtered impurities.The filtrate was distilled off under reduced pressure and toluene was added 100mL of methylene chloride and methanol to precipitate the product catalyst 5L solid was filtered and dried to give the final catalyst 330g, 65% yield.
246047-72-3, As the paragraph descriping shows that 246047-72-3 is playing an increasingly important role.
Reference£º
Patent; Shanghai Keqin Technology Co., Ltd.; Zhang Wei; Wu Jiang; Zhu Chunyin; (26 pag.)CN106939026; (2017); A;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI